BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 19142110)

  • 1. Association between HTR2C and HTR2A polymorphisms and metabolic abnormalities in patients treated with olanzapine or clozapine.
    Gunes A; Melkersson KI; Scordo MG; Dahl ML
    J Clin Psychopharmacol; 2009 Feb; 29(1):65-8. PubMed ID: 19142110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of serotonin receptor 2A gene haplotypes on C-peptide levels in clozapine- and olanzapine-treated patients.
    Melkersson KI; Gunes A; Dahl ML
    Hum Psychopharmacol; 2010; 25(4):347-52. PubMed ID: 20521326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HTR2C polymorphisms, olanzapine-induced weight gain and antipsychotic-induced metabolic syndrome in schizophrenia patients: a meta-analysis.
    Ma X; Maimaitirexiati T; Zhang R; Gui X; Zhang W; Xu G; Hu G
    Int J Psychiatry Clin Pract; 2014 Oct; 18(4):229-42. PubMed ID: 25152019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple genetic factors in olanzapine-induced weight gain in schizophrenia patients: a cohort study.
    Ujike H; Nomura A; Morita Y; Morio A; Okahisa Y; Kotaka T; Kodama M; Ishihara T; Kuroda S
    J Clin Psychiatry; 2008 Sep; 69(9):1416-22. PubMed ID: 19193342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olanzapine-induced weight gain is associated with the -759C/T and -697G/C polymorphisms of the HTR2C gene.
    Godlewska BR; Olajossy-Hilkesberger L; Ciwoniuk M; Olajossy M; Marmurowska-Michałowska H; Limon J; Landowski J
    Pharmacogenomics J; 2009 Aug; 9(4):234-41. PubMed ID: 19434072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between HTR2C gene polymorphisms and the metabolic syndrome in patients with schizophrenia.
    Mulder H; Franke B; van der-Beek van der AA; Arends J; Wilmink FW; Scheffer H; Egberts AC
    J Clin Psychopharmacol; 2007 Aug; 27(4):338-43. PubMed ID: 17632216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HTR2C gene polymorphisms and the metabolic syndrome in patients with schizophrenia: a replication study.
    Mulder H; Cohen D; Scheffer H; Gispen-de Wied C; Arends J; Wilmink FW; Franke B; Egberts AC
    J Clin Psychopharmacol; 2009 Feb; 29(1):16-20. PubMed ID: 19142101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between HTR2C polymorphisms and metabolic syndrome in patients with schizophrenia treated with atypical antipsychotics.
    Bai YM; Chen TT; Liou YJ; Hong CJ; Tsai SJ
    Schizophr Res; 2011 Feb; 125(2-3):179-86. PubMed ID: 21185157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin and dopamine receptor gene polymorphisms and the risk of extrapyramidal side effects in perphenazine-treated schizophrenic patients.
    Gunes A; Scordo MG; Jaanson P; Dahl ML
    Psychopharmacology (Berl); 2007 Mar; 190(4):479-84. PubMed ID: 17102980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HTR2C haplotypes and antipsychotics-induced weight gain: X-linked multimarker analysis.
    De Luca V; Müller DJ; Hwang R; Lieberman JA; Volavka J; Meltzer HY; Kennedy JL
    Hum Psychopharmacol; 2007 Oct; 22(7):463-7. PubMed ID: 17702092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene polymorphism influencing treatment response in psychotic patients in a naturalistic setting.
    Alenius M; Wadelius M; Dahl ML; Hartvig P; Lindström L; Hammarlund-Udenaes M
    J Psychiatr Res; 2008 Sep; 42(11):884-93. PubMed ID: 18086475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of association between the -759C/T polymorphism of the 5-HT2C receptor gene and olanzapine-induced weight gain among Korean schizophrenic patients.
    Park YM; Cho JH; Kang SG; Choi JE; Lee SH; Kim L; Lee HJ
    J Clin Pharm Ther; 2008 Feb; 33(1):55-60. PubMed ID: 18211617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low gene expression conferred by association of an allele of the 5-HT2C receptor gene with antipsychotic-induced weight gain.
    Buckland PR; Hoogendoorn B; Guy CA; Smith SK; Coleman SL; O'Donovan MC
    Am J Psychiatry; 2005 Mar; 162(3):613-5. PubMed ID: 15741483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms of the leptin and HTR2C genes and clozapine-induced weight change and baseline BMI in patients with chronic schizophrenia.
    Kang SH; Lee JI; Han HR; Soh M; Hong JP
    Psychiatr Genet; 2014 Dec; 24(6):249-56. PubMed ID: 25304226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute Necrotizing Pancreatitis Following Olanzapine Treatment and 759C/T Polymorphism of HTR2C Gene: A Case Report.
    Rizos E; Tournikioti K; Alevyzakis E; Peppa M; Papazaxos K; Zorbas G; Michopoulos I; Liappas I; Papageorgiou C; Douzenis A
    In Vivo; 2015; 29(5):529-31. PubMed ID: 26359410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allelic variation in ApoC3, ApoA5 and LPL genes and first and second generation antipsychotic effects on serum lipids in patients with schizophrenia.
    Smith RC; Segman RH; Golcer-Dubner T; Pavlov V; Lerer B
    Pharmacogenomics J; 2008 Jun; 8(3):228-36. PubMed ID: 17726453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetics and olanzapine treatment: CYP1A2*1F and serotonergic polymorphisms influence therapeutic outcome.
    Laika B; Leucht S; Heres S; Schneider H; Steimer W
    Pharmacogenomics J; 2010 Feb; 10(1):20-9. PubMed ID: 19636338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine (DRD2) and Serotonin (HTR2A, 2C) Receptor Gene Polymorphisms do not influence early response to Risperidone in South Indian Patients with Schizophrenia.
    Alladi CG; RajKumar RP; Adithan S; Marie-Claire C; Bellivier F; Shewade DG
    Fundam Clin Pharmacol; 2019 Jun; 33(3):355-364. PubMed ID: 30332506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association study of MDR1 and 5-HT2C genetic polymorphisms and antipsychotic-induced metabolic disturbances in female patients with schizophrenia.
    Kuzman MR; Medved V; Bozina N; Grubišin J; Jovanovic N; Sertic J
    Pharmacogenomics J; 2011 Feb; 11(1):35-44. PubMed ID: 20195292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis.
    Henderson DC; Cagliero E; Copeland PM; Borba CP; Evins AE; Hayden D; Weber MT; Anderson EJ; Allison DB; Daley TB; Schoenfeld D; Goff DC
    Arch Gen Psychiatry; 2005 Jan; 62(1):19-28. PubMed ID: 15630069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.